Fendler, Wolfgang P., Kratochwil, Clemens, Ahmadzadehfar, Hojjat, Rahbar, Kambiz ORCID: 0000-0002-4591-4055, Baum, Richard P., Schmidt, Matthias, Pfestroff, Andreas, Luetzen, Ulf, Prasad, Vikas ORCID: 0000-0003-2010-4117, Heinzel, Alexander ORCID: 0000-0002-2430-4557, Heuschkel, Martin, Ruf, Juri, Bartenstein, Peter and Krause, Bernd J. (2016). Lu-177-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer. Nuklearmedizin, 55 (3). S. 123 - 129. STUTTGART: GEORG THIEME VERLAG KG. ISSN 2567-6407

Full text not available from this repository.

Abstract

Radioligand therapy (RLT) using Lu-177 labelled inhibitors of the prostate-specific membrane antigen (Lu-177-PSMA) is performed in patients with metastatic castration-resistant prostate cancer (mCRPC) after exhaustion of other options. German University Clinics offer RLT since 2013 on a compassionate use basis. The present consensus document includes recommendations for RLT with Lu-177-PSMA-617. These consensus statements were developed by an expert panel formed by the German Society of Nuclear Medicine (DGN) in December 2015. Statements include recommendations for indication, baseline tests, therapy protocol, concomitant therapy, dosimetry, and follow-up. Consensus recommendations aim to inform the attending medical staff, standardize Lu-177-PSMA-617 RLT, and improve quality of individual patient care.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Fendler, Wolfgang P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kratochwil, ClemensUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ahmadzadehfar, HojjatUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rahbar, KambizUNSPECIFIEDorcid.org/0000-0002-4591-4055UNSPECIFIED
Baum, Richard P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schmidt, MatthiasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pfestroff, AndreasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Luetzen, UlfUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Prasad, VikasUNSPECIFIEDorcid.org/0000-0003-2010-4117UNSPECIFIED
Heinzel, AlexanderUNSPECIFIEDorcid.org/0000-0002-2430-4557UNSPECIFIED
Heuschkel, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ruf, JuriUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bartenstein, PeterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Krause, Bernd J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-289629
DOI: 10.1055/s-0037-1616480
Journal or Publication Title: Nuklearmedizin
Volume: 55
Number: 3
Page Range: S. 123 - 129
Date: 2016
Publisher: GEORG THIEME VERLAG KG
Place of Publication: STUTTGART
ISSN: 2567-6407
Language: German
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
RECEPTOR RADIONUCLIDE THERAPY; DISEASE; TUMORSMultiple languages
Radiology, Nuclear Medicine & Medical ImagingMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/28962

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item